Literature DB >> 12573898

Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan.

Shu-Li Wang1, Jeng-Min Chiou, Chien-Jen Chen, Chin-Hsiao Tseng, Wei-Ling Chou, Cheng-Chung Wang, Trong-Neng Wu, Louis W Chang.   

Abstract

There is evidence indicating that ingestion of arsenic may predispose the development of diabetes mellitus in arsenic-endemic areas in Taiwan. However, the prevalence of diabetes and related vascular diseases in the entire southwestern arseniasis-endemic and nonendemic areas remains to be elucidated. We used the National Health Insurance Database for 1999-2000 to derive the prevalence of non-insulin-dependent diabetes and related vascular diseases by age and sex among residents in southwestern arseniasis-endemic and nonendemic areas in Taiwan. The study included 66,667 residents living in endemic areas and 639,667 in nonendemic areas, all greater than or equal to 25 years of age. The status of diabetes and vascular diseases was ascertained through disease diagnosis and treatment prescription included in the reimbursement claims of clinics and hospitals. The prevalence of non-insulin-dependent diabetes, age- and gender-adjusted to the general population in Taiwan, was 7.5% (95% confidence interval, 7.4-7.7%) in the arseniasis-endemic areas and 3.5% (3.5-3.6%) in the nonendemic areas. Among both diabetics and nondiabetics, higher prevalence of microvascular and macrovascular diseases was observed in arseniasis-endemic than in the nonendemic areas. Age- and gender-adjusted prevalence of microvascular disease in endemic and nonendemic areas was 20.0% and 6.0%, respectively, for diabetics, and 8.6% and 1.0%, respectively, for nondiabetics. The corresponding prevalence of macrovascular disease was 25.3% and 13.7% for diabetics, and 12.3% and 5.5% for nondiabetics. Arsenic has been suggested to increase the risk of non-insulin-dependent diabetes mellitus and its related micro- and macrovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573898      PMCID: PMC1241343          DOI: 10.1289/ehp.5457

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  40 in total

1.  Arsenic induced neuropathy.

Authors:  S K Mahajan; H K Aggarwal; N Wig; S Maitra; S N Chugh
Journal:  J Assoc Physicians India       Date:  1992-04

2.  Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure.

Authors:  C J Chen; H Y Chiou; M H Chiang; L J Lin; T Y Tai
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-04       Impact factor: 8.311

3.  Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan.

Authors:  C H Tseng; C K Chong; C J Chen; T Y Tai
Journal:  Atherosclerosis       Date:  1996-02       Impact factor: 5.162

4.  Increased neurotoxicity of arsenic in methylenetetrahydrofolate reductase deficiency.

Authors:  O F Brouwer; W Onkenhout; P M Edelbroek; J F de Kom; F A de Wolff; A C Peters
Journal:  Clin Neurol Neurosurg       Date:  1992       Impact factor: 1.876

5.  Ingested inorganic arsenic and prevalence of diabetes mellitus.

Authors:  M S Lai; Y M Hsueh; C J Chen; M P Shyu; S Y Chen; T L Kuo; M M Wu; T Y Tai
Journal:  Am J Epidemiol       Date:  1994-03-01       Impact factor: 4.897

6.  Prevalence of diabetes mellitus in Japan compiled from literature.

Authors:  T Kuzuya
Journal:  Diabetes Res Clin Pract       Date:  1994-10       Impact factor: 5.602

7.  Increased prevalence of hypertension and long-term arsenic exposure.

Authors:  C J Chen; Y M Hsueh; M S Lai; M P Shyu; S Y Chen; M M Wu; T L Kuo; T Y Tai
Journal:  Hypertension       Date:  1995-01       Impact factor: 10.190

8.  Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter.

Authors:  M Rahman; O Axelson
Journal:  Occup Environ Med       Date:  1995-11       Impact factor: 4.402

9.  Diabetes mellitus among Swedish art glass workers--an effect of arsenic exposure?

Authors:  M Rahman; G Wingren; O Axelson
Journal:  Scand J Work Environ Health       Date:  1996-04       Impact factor: 5.024

10.  Influence of 2,3-dimercaptopropanol and other sulfur compounds on oxophenylarsine-mediated inhibition of glucose uptake in MDCK cells.

Authors:  B Liebl; H Mückter; E Doklea; B Fichtl; W Forth
Journal:  Analyst       Date:  1995-03       Impact factor: 4.616

View more
  36 in total

1.  Association of Urinary and Blood Concentrations of Heavy Metals with Measures of Bone Mineral Density Loss: a Data Mining Approach with the Results from the National Health and Nutrition Examination Survey.

Authors:  João Paulo B Ximenez; Ariane Zamarioli; Melissa A Kacena; Rommel Melgaço Barbosa; Fernando Barbosa
Journal:  Biol Trace Elem Res       Date:  2020-04-30       Impact factor: 3.738

2.  Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice.

Authors:  Nicole V Soucy; Debra Mayka; Linda R Klei; Antonia A Nemec; John A Bauer; Aaron Barchowsky
Journal:  Cardiovasc Toxicol       Date:  2005       Impact factor: 3.231

3.  Predicting arsenic concentrations in groundwater of San Luis Valley, Colorado: implications for individual-level lifetime exposure assessment.

Authors:  Katherine A James; Jaymie R Meliker; Barbara E Buttenfield; Tim Byers; Gary O Zerbe; John E Hokanson; Julie A Marshall
Journal:  Environ Geochem Health       Date:  2014-01-16       Impact factor: 4.609

4.  Association between arsenic exposure from drinking water and proteinuria: results from the Health Effects of Arsenic Longitudinal Study.

Authors:  Yu Chen; Faruque Parvez; Mengling Liu; Gene R Pesola; Mary V Gamble; Vesna Slavkovich; Tariqul Islam; Alauddin Ahmed; Rabiul Hasan; Joseph H Graziano; Habibul Ahsan
Journal:  Int J Epidemiol       Date:  2011-02-22       Impact factor: 7.196

5.  Targeted metabolomics to understand the association between arsenic metabolism and diabetes-related outcomes: Preliminary evidence from the Strong Heart Family Study.

Authors:  Miranda J Spratlen; Maria Grau-Perez; Jason G Umans; Joseph Yracheta; Lyle G Best; Kevin Francesconi; Walter Goessler; Teodoro Bottiglieri; Mary V Gamble; Shelley A Cole; Jinying Zhao; Ana Navas-Acien
Journal:  Environ Res       Date:  2018-09-27       Impact factor: 6.498

6.  Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study.

Authors:  Matthew O Gribble; Barbara V Howard; Jason G Umans; Nawar M Shara; Kevin A Francesconi; Walter Goessler; Ciprian M Crainiceanu; Ellen K Silbergeld; Eliseo Guallar; Ana Navas-Acien
Journal:  Am J Epidemiol       Date:  2012-10-24       Impact factor: 4.897

7.  The Association of Arsenic Exposure and Arsenic Metabolism With the Metabolic Syndrome and Its Individual Components: Prospective Evidence From the Strong Heart Family Study.

Authors:  Miranda J Spratlen; Maria Grau-Perez; Lyle G Best; Joseph Yracheta; Mariana Lazo; Dhananjay Vaidya; Poojitha Balakrishnan; Mary V Gamble; Kevin A Francesconi; Walter Goessler; Shelley A Cole; Jason G Umans; Barbara V Howard; Ana Navas-Acien
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

8.  Arsenic-induced decreases in the vascular matrix.

Authors:  Allison M Hays; R Clark Lantz; Laurel S Rodgers; James J Sollome; Richard R Vaillancourt; Angeline S Andrew; Joshua W Hamilton; Todd D Camenisch
Journal:  Toxicol Pathol       Date:  2008-09-23       Impact factor: 1.902

9.  Deficiency in the nuclear factor E2-related factor 2 renders pancreatic β-cells vulnerable to arsenic-induced cell damage.

Authors:  Bei Yang; Jingqi Fu; Hongzhi Zheng; Peng Xue; Kathy Yarborough; Courtney G Woods; Yongyong Hou; Qiang Zhang; Melvin E Andersen; Jingbo Pi
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-21       Impact factor: 4.219

10.  Second-hand smoke and chronic bronchitis in Taiwanese women: a health-care based study.

Authors:  Chia-Fang Wu; Nan-Hsiung Feng; Inn-Wen Chong; Kuen-Yuh Wu; Chien-Hung Lee; Jhi-Jhu Hwang; Chia-Tsuan Huang; Chung-Ying Lee; Shao-Ting Chou; David C Christiani; Ming-Tsang Wu
Journal:  BMC Public Health       Date:  2010-01-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.